Login to Download
PDF version

Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. J Surg Res. 2007;143(1):1–12 .

36. Dumfarth J, Zimpfer D, Vogele-Kadletz M, et al. Prophylactic low-energy shock wave therapy improves wound healing after vein harvesting for coronary artery bypass graft surgery: a prospective, randomized trial. Ann Thorac Surg. 2008;86(6):1909–1913.

37. Horn C, Gerdesmeyer L, von Eiff C, Gradinger R, Gollwitzer H. Energy-dependent stimulatory and inhibitory effects of extracorporeal shock waves on bacteria and on gentamicin activity. Med Sci Monit. 2009;15(6):MT77–MT83.

38. Novak KF, Govindaswami M, Ebersole JL, et al. Effects of low-energy shock waves on oral bacteria. J Dent Res. 2008;87(10):928-931.

39. Gerdesmeyer L, von Eiff C, Horn C, et al. Antibacterial effects of extracorporeal shock waves. Ultrasound Med Biol. 2005;31(1):115–119.

40. Gollwitzer H, Horn C, Von Eiff C, Henne M, Gerdesmeyer L. Antibacterial effectiveness of high-energetic extracorporeal shock waves: an in vitro verification. Z Orthop Ihre Grenzgeb. 2004;142(4):462–466. [Article in German].

41. Ottomann C, Stojadinovic A, Lavin PT. Prospective randomized Phase II trial of accelerated re-epithelization of superficial second degree burn wounds using ESWT. Ann Surg. In press.

42. Arno A, Garcia O, Hernan I, et al. Extracorporeal shock waves, a new non-surgical method to treat severe burns. Burns. 2010;36(6):844–849.

43. Saggini R, Figus A, Troccola A, et al. Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities. Ultrasound Med Biol. 2008;34(8):1261–1271.

44. Furia JP, Rompe JD, & Maffulli N. Low-energy extracorporeal shock wave therapy as a treatment for greater trochanteric pain syndrome. Am J Sports Med. 2009;37(9):1806–1813.

45. Sabeti M, Dorotka R, Goll A, Gruber M, Schatz KD. A comparison of two different treatments with navigated extracorporeal shock-wave therapy for calcifying tendinitis—a randomized controlled trial. Wien Klin Wochenschr. 2007;119(3-4):124–128.

46. Moretti B, Notarnicola A, Maggio G, et al. The management of neuropathic ulcers of the foot in diabetes by shock wave therapy. BMC Musculoskelet Disord. 2009;10:54.

47. Larking AM, Duport S, Clinton M, Hardy M, Andrews K. Randomized control of extracorporeal shock wave therapy versus placebo for chronic decubitus ulceration. Clin Rehabil. 2010;24(3):222–229.

48. Bonomo SR, Davidson JD, Tyrone JW, Lin X, Mustoe TA. Enhancement of wound healing by hyperbaric oxygen and transforming growth factor beta3 in a new chronic wound model in aged rabbits. Arch Surg. 2000;135(10):1148–1153.

49. Fife CE, Buyukcakir C, Otto GH, et al. The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1,144 patients. Wound Repair Regen. 2002;10(4):198–207.

50. Smith BM, Desvigne LD, Slade JB, Dooley JW, Warren DC. Transcutaneous oxygen measurements predict healing of leg wounds with hyperbaric therapy. Wound Repair Regen. 1996;4(2):224–229.

51. Zhao LL, Davidson JD, Wee SC, Roth SI, Mustoe TA. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg. 1994;129(10):1043–1049.

52. Wang CJ, Kuo YR, Wu RW, et al. Extracorporeal shockwave treatment for chronic diabetic foot ulcers. J Surg Res. 2009;152(1):96–103.

53. Wang CJ, Wu RW,Yang YJ. Treatment of diabetic foot ulcers: A comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Res Clin Pract. 2011;92(2):187–193; Epub.

54. Sanuwave, Inc. Sanuwave Announces Positive Top-Line Data from its Pivotal Trial Investigating the Use of DermaPACE for the Treatment of Diabetic Foot Ulcers. Available at: www.sanuwave.com.